Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,364 | 78 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $401.55 | 22 | $0 (2024) |
| PFIZER INC. | $318.96 | 19 | $0 (2024) |
| Celgene Corporation | $241.33 | 14 | $0 (2024) |
| Janssen Biotech, Inc. | $126.63 | 6 | $0 (2022) |
| Ardelyx, Inc. | $55.89 | 3 | $0 (2023) |
| GENZYME CORPORATION | $49.16 | 2 | $0 (2024) |
| Cumberland Pharmaceuticals, Inc. | $46.48 | 4 | $0 (2021) |
| AIMMUNE THERAPEUTICS, INC. | $35.82 | 2 | $0 (2024) |
| Gilead Sciences, Inc. | $27.07 | 2 | $0 (2021) |
| INTRA-SANA LABORATORIES | $23.84 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $497.56 | 27 | PFIZER INC. ($238.48) |
| 2023 | $288.26 | 16 | Celgene Corporation ($99.63) |
| 2022 | $368.86 | 22 | ABBVIE INC. ($154.57) |
| 2021 | $165.60 | 9 | Janssen Biotech, Inc. ($66.75) |
| 2019 | $12.47 | 1 | Cumberland Pharmaceuticals, Inc. ($12.47) |
| 2018 | $22.61 | 2 | Cumberland Pharmaceuticals, Inc. ($22.61) |
| 2017 | $8.99 | 1 | QOL Medical, LLC ($8.99) |
All Payment Transactions
78 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/19/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $5.96 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/05/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.48 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/04/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $31.53 | General |
| Category: IMMUNOLOGY | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $2.10 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/30/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 10/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $21.90 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $22.05 | General |
| Category: Neuroscience | ||||||
| 08/29/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $2.80 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 08/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Immunology | ||||||
| 08/06/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/24/2024 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ, HUMIRA | Food and Beverage | In-kind items and services | $27.11 | General |
| Category: IMMUNOLOGY | ||||||
| 07/15/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $23.58 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 07/09/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $18.43 | General |
| Category: Neuroscience | ||||||
| 05/31/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 05/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 05/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 04/25/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: GASTROENTEROLOGY | ||||||
| 04/03/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.47 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/25/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: IMMUNOLOGY | ||||||
| 03/12/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $22.76 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/11/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $25.50 | General |
| Category: Immunology | ||||||
| 02/21/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $19.66 | General |
| Category: Neuroscience | ||||||
| 02/13/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,800 | 2,101 | $1.3M | $283,156 |
| 2022 | 28 | 2,549 | 2,947 | $1.5M | $364,927 |
| 2021 | 27 | 1,821 | 2,062 | $1.1M | $299,895 |
| 2020 | 29 | 1,224 | 1,410 | $540,600 | $136,319 |
All Medicare Procedures & Services
98 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 175 | 176 | $375,455 | $75,944 | 20.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 156 | 158 | $217,380 | $47,752 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 464 | 629 | $181,540 | $47,594 | 26.2% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2023 | 117 | 117 | $180,775 | $32,793 | 18.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 218 | 259 | $106,190 | $27,598 | 26.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 184 | 184 | $72,520 | $15,622 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 104 | 104 | $61,025 | $14,743 | 24.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 50 | 52 | $86,630 | $13,457 | 15.5% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 89 | 92 | $13,900 | $4,626 | 33.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 108 | 157 | $4,865 | $1,312 | 27.0% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 66 | 96 | $3,180 | $730.56 | 23.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 38 | 46 | $2,000 | $476.10 | 23.8% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 17 | 17 | $1,235 | $279.82 | 22.7% |
| 82105 | Alpha-fetoprotein (afp) level, serum | Office | 2023 | 14 | 14 | $1,050 | $230.02 | 21.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 190 | 191 | $324,700 | $80,937 | 24.9% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 167 | 169 | $223,080 | $52,915 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 443 | 637 | $165,620 | $51,057 | 30.8% |
| 45378 | Diagnostic exam of large bowel using a flexible endoscope | Office | 2022 | 161 | 161 | $225,400 | $46,755 | 20.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 273 | 339 | $128,820 | $37,854 | 29.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 218 | 218 | $83,930 | $20,149 | 24.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 132 | 132 | $76,560 | $20,008 | 26.1% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 51 | 51 | $77,520 | $16,390 | 21.1% |
| 45382 | Control of bleeding of upper large bowel using a flexible endoscope | Office | 2022 | 17 | 17 | $46,075 | $11,707 | 25.4% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 287 | 300 | $45,000 | $10,449 | 23.2% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 150 | 157 | $23,650 | $7,942 | 33.6% |
About Dr. Adam Beckerman, MD
Dr. Adam Beckerman, MD is a Gastroenterology healthcare provider based in Seaford, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1518956366.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Beckerman, MD has received a total of $1,364 in payments from pharmaceutical and medical device companies, with $497.56 received in 2024. These payments were reported across 78 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($1,364).
As a Medicare-enrolled provider, Beckerman has provided services to 7,394 Medicare beneficiaries, totaling 8,520 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 98 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location Seaford, NY
- Active Since 10/14/2005
- Last Updated 12/09/2009
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1518956366
Products in Payments
- XELJANZ (Drug) $299.55
- ZEPOSIA (Drug) $207.13
- LINZESS (Drug) $135.12
- SKYRIZI (Biological) $91.04
- CREON (Drug) $71.50
- REMICADE (Biological) $71.49
- STELARA (Biological) $68.49
- IBSRELA (Drug) $55.89
- DUPIXENT (Biological) $49.16
- VIBERZI (Drug) $47.40
- ZENPEP (Drug) $35.82
- RINVOQ (Biological) $31.53
- HUMIRA (Biological) $24.96
- RELTONE 200 MG (Drug) $23.84
- Omeclamox (Drug) $22.61
- VELSIPITY (Drug) $19.41
- GI GENIUS (Device) $15.28
- Kristalose 20gm (Drug) $12.47
- KRISTALOSE (Drug) $11.40
- Sucraid (Drug) $8.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Seaford
Dr. Ismet Lukolic, M.d, M.D
Gastroenterology — Payments: $6,753
Dr. Bradley Mackler, M.d, M.D
Gastroenterology — Payments: $4,386
Dr. Ronald Concha Parra, Md, MD
Gastroenterology — Payments: $3,019
Corina Serer, Md, MD
Gastroenterology — Payments: $2,293
Theodore Perlman, Md, MD
Gastroenterology — Payments: $1,930
Lester Goldblum, Do, DO
Gastroenterology — Payments: $75.50